BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33208620)

  • 1. Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on 18F-Prostate-Specific Membrane Antigen-1007 PET/CT.
    Soeda F; Watabe T; Kato H; Uemura M; Nonomura N
    Clin Nucl Med; 2021 Jan; 46(1):49-51. PubMed ID: 33208620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
    Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
    Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of
    Rahbar K; Afshar-Oromieh A; Seifert R; Wagner S; Schäfers M; Bögemann M; Weckesser M
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2055-2061. PubMed ID: 30027419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.
    Broos WAM; Kocken M; van der Zant FM; Knol RJJ; Wondergem M
    Clin Nucl Med; 2018 Feb; 43(2):120-122. PubMed ID: 29261618
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
    Chen B; Macapinlac HA; Lu Y
    Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
    Panagiotidis E; Paschali A; Giannoula E; Chatzipavlidou V
    Clin Nucl Med; 2019 Jan; 44(1):e46-e48. PubMed ID: 30371591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET.
    Arçay A; Eiber M; Langbein T
    Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to
    Adnan A; Basu S
    J Nucl Med Technol; 2020 Jun; 48(2):148-153. PubMed ID: 32111660
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Akdemir EN; Tuncel M; Akyol F; Bilen CY; Baydar DE; Karabulut E; Ozen H; Caglar M
    World J Urol; 2019 May; 37(5):813-821. PubMed ID: 30151600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer.
    Liu BL; Hong JJ; Tang K; Lin J; Zheng XW
    Clin Nucl Med; 2021 Jul; 46(7):e355-e357. PubMed ID: 33782286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml.
    Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):343-348. PubMed ID: 31780781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.
    Ji X; Wang L; Lin J; Tang K
    Clin Nucl Med; 2022 Jan; 47(1):e74-e76. PubMed ID: 34238806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High detection rate in [
    Watabe T; Uemura M; Soeda F; Naka S; Ujike T; Hatano K; Sasaki H; Kamiya T; Shimosegawa E; Kato H; Cardinale J; Tateishi U; Nonomura N; Giesel FL
    Ann Nucl Med; 2021 Apr; 35(4):523-528. PubMed ID: 33661475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.
    Bilgin R; Ergül N; Çermik TF
    Clin Nucl Med; 2016 Dec; 41(12):956-958. PubMed ID: 27824323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer.
    Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A
    Clin Nucl Med; 2019 Dec; 44(12):e629-e633. PubMed ID: 31689286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between molecular tumor volume evaluated with
    Medina-Ornelas Sevastián S; García-Pérez Francisco O; Hernández-Pedro Norma Y; Arellano-Zarate Angélica E; Abúndiz-López Blanca L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):223-228. PubMed ID: 29454548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.